Skip to content
10-Q

Quarterly Report

ALEXION PHARMACEUTICALS, INC.

0000899866-21-000039

← back to feed
Filed
Apr 30, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 28, 2021 221.02M sh
Shares Diluted Q1 2021 · Mar 31, 2021 222.6M sh
Shares Diluted Q1 2021 · Mar 31, 2020 222.6M sh
Stock Repurchased Q1 2021 · Mar 31, 2021 $0
Stock Repurchased Q1 2021 · Mar 31, 2020 $107.1M
Capex Q1 2021 · Mar 31, 2021 $20.2M
Capex Q1 2021 · Mar 31, 2020 $12.2M
Operating Cash Flow Q1 2021 · Mar 31, 2021 $637.6M
Operating Cash Flow Q1 2021 · Mar 31, 2020 $549.6M
Long Term Debt Q1 2021 · Mar 31, 2021 $2.39B
Long Term Debt Q1 2021 · Dec 31, 2020 $2.42B
Short Term Debt Q1 2021 · Mar 31, 2021 $143.2M
Short Term Debt Q1 2021 · Dec 31, 2020 $142.4M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $3.43B
Cash And Equivalents Q1 2021 · Dec 31, 2020 $2.96B
Cash And Equivalents Q1 2021 · Mar 31, 2020 $2.32B
Stockholders Equity Q1 2021 · Mar 31, 2021 $12.42B
Stockholders Equity Q1 2021 · Dec 31, 2020 $11.65B
Current Liabilities Q1 2021 · Mar 31, 2021 $1.43B
Current Liabilities Q1 2021 · Dec 31, 2020 $1.62B
Total Liabilities Q1 2021 · Mar 31, 2021 $6.22B
Total Liabilities Q1 2021 · Dec 31, 2020 $6.45B
Current Assets Q1 2021 · Mar 31, 2021 $6.45B
Current Assets Q1 2021 · Dec 31, 2020 $5.83B
Total Assets Q1 2021 · Mar 31, 2021 $18.65B
Total Assets Q1 2021 · Dec 31, 2020 $18.1B
Eps Diluted Q1 2021 · Mar 31, 2021 $2.86
Eps Diluted Q1 2021 · Mar 31, 2020 $2.50
Eps Basic Q1 2021 · Mar 31, 2021 $2.89
Eps Basic Q1 2021 · Mar 31, 2020 $2.52
Sga Expense Q1 2021 · Mar 31, 2021 $342.9M
Sga Expense Q1 2021 · Mar 31, 2020 $319.9M
Net Income Q1 2021 · Mar 31, 2021 $636M
Net Income Q1 2021 · Mar 31, 2020 $557.6M
Operating Income Q1 2021 · Mar 31, 2021 $636.2M
Operating Income Q1 2021 · Mar 31, 2020 $695.5M
Revenue Q1 2021 · Mar 31, 2021 $1.64B
Revenue Q1 2021 · Mar 31, 2020 $1.44B